九尊數字互娛(01961.HK):經紀股份代價及38.66 %經紀股份已交付予各交易對手的經紀
格隆匯2月8日丨九尊數字互娛(01961.HK)公佈,有關公司獲Infinities Global Technology Limited Partnership折讓約27.63%提收購要約事項,完成已於2022年1月20日落實,而交叉盤指令將於該公吿刊發後股份恢復買賣時執行。
要約人及董事會謹此通知股東,賣方二、賣方三及要約人各自的證券經紀已於2022年2月8日就銷售股份二及銷售股份三的支付及交付執行交叉盤指令。執行交叉盤指令後,經紀股份代價及38.66 %經紀股份已交付予各交易對手的經紀。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.